<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38020953</PMID><DateRevised><Year>2023</Year><Month>12</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2455-4626</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Season>Jul-Sep</Season></PubDate></JournalIssue><Title>Brain circulation</Title><ISOAbbreviation>Brain Circ</ISOAbbreviation></Journal><ArticleTitle>Neuropsychiatric manifestations in patients with long COVID in Mexico.</ArticleTitle><Pagination><StartPage>196</StartPage><EndPage>197</EndPage><MedlinePgn>196-197</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/bc.bc_13_23</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Carpio-Orantes</LastName><ForeName>Luis Del</ForeName><Initials>LD</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Study Group for the Diagnosis and Treatment of COVID-19 in Veracruz, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguilar-Silva</LastName><ForeName>Andr&#xe9;s</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Study Group for the Diagnosis and Treatment of COVID-19 in Veracruz, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-M&#xe9;ndez</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Study Group for the Diagnosis and Treatment of COVID-19 in Veracruz, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;nchez-Diaz</LastName><ForeName>Jes&#xfa;s Salvador</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Study Group for the Diagnosis and Treatment of COVID-19 in Veracruz, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez-Contreras</LastName><ForeName>Yamir</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Study Group for the Diagnosis and Treatment of COVID-19 in Veracruz, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lara-Hern&#xe1;ndez</LastName><ForeName>Estefan&#xed;a</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Study Group for the Diagnosis and Treatment of COVID-19 in Veracruz, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-M&#xe1;rquez</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Study Group for the Diagnosis and Treatment of COVID-19 in Veracruz, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Brain Circ</MedlineTA><NlmUniqueID>101669876</NlmUniqueID><ISSNLinking>2394-8108</ISSNLinking></MedlineJournalInfo><CoiStatement>There are no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>29</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>29</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>29</Day><Hour>14</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38020953</ArticleId><ArticleId IdType="pmc">PMC10679627</ArticleId><ArticleId IdType="doi">10.4103/bc.bc_13_23</ArticleId><ArticleId IdType="pii">BC-9-196</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Del Carpio-Orantes L. Proposal for a diagnostic approach to long COVID. Rev Med Inst Mex Seguro Soc. 2023;61:403&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10484538</ArticleId><ArticleId IdType="pubmed">37535946</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Carpio-Orantes L, Aguilar-Silva A. Intertwined long COVID theories to explain its etiopathogenesis. Rev Med Inst Mex Seguro Soc. 2023;61:256&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10437229</ArticleId><ArticleId IdType="pubmed">37216305</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re' em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera-Garc&#xed; a JC, Arellano-Montellano EI, Ju&#xe1; rez-Gonz&#xe1; lez LI, Contreras-Andrade RI. Persistence of symptoms in patients after coronavirus disease (COVID-19) in a third level hospital of Puebla, Mexico. Med Int Mex. 2020;36:789&#x2013;93.</Citation></Reference><Reference><Citation>Galv&#xe1; n-Tejada CE, Herrera-Garc&#xed; a CF, Godina-Gonz&#xe1; lez S, Villagrana-Ba&#xf1; uelos KE, Amaro JD, Herrera-Garc&#xed; a K, et al. Persistence of COVID-19 symptoms after recovery in Mexican population. Int J Environ Res Public Health. 2020;17:9367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7765113</ArticleId><ArticleId IdType="pubmed">33327641</ArticleId></ArticleIdList></Reference><Reference><Citation>Cort&#xe9; s-Telles A, L&#xf3; pez-Romero S, Figueroa-Hurtado E, Pou-Aguilar YN, Wong AW, Milne KM, et al. Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea. Respir Physiol Neurobiol. 2021;288:103644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7910142</ArticleId><ArticleId IdType="pubmed">33647535</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong AW, L&#xf3; pez-Romero S, Figueroa-Hurtado E, Vazquez-Lopez S, Milne KM, Ryerson CJ, et al. Predictors of reduced 6-minute walk distance after COVID-19: A cohort study in Mexico. Pulmonology. 2021;27:563&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7997705</ArticleId><ArticleId IdType="pubmed">33832849</ArticleId></ArticleIdList></Reference><Reference><Citation>Qui&#xf1; ones-Moya H, Valle AO, Camargo-Coronel A, Jimen&#xe9; nez-Balderas FJ, Bernal-Enriquez MB, Madinabeitia-Rodr&#xed; guez P, et al. Long COVID in patients with rheumatologic disease: A single center observational study. Indian J Rheumatol. 2022 [doi: 10.4103/injr.injr_ 118_ 22]</Citation></Reference><Reference><Citation>Del Carpio-Orantes L. Etiopathogenic theories about long COVID. World J Virol. 2023;12:204&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10311581</ArticleId><ArticleId IdType="pubmed">37396704</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>